Titre : Poumon hyperclair

Poumon hyperclair : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cognitive Dysfunction
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Poumon hyperclair : Questions médicales les plus fréquentes", "headline": "Poumon hyperclair : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Poumon hyperclair : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-19", "dateModified": "2025-02-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Poumon hyperclair" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies pulmonaires", "url": "https://questionsmedicales.fr/mesh/D008171", "about": { "@type": "MedicalCondition", "name": "Maladies pulmonaires", "code": { "@type": "MedicalCode", "code": "D008171", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.381" } } }, "about": { "@type": "MedicalCondition", "name": "Poumon hyperclair", "alternateName": "Lung, Hyperlucent", "code": { "@type": "MedicalCode", "code": "D019568", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hiromichi Niikawa", "url": "https://questionsmedicales.fr/author/Hiromichi%20Niikawa", "affiliation": { "@type": "Organization", "name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan." } }, { "@type": "Person", "name": "Kenneth R McCurry", "url": "https://questionsmedicales.fr/author/Kenneth%20R%20McCurry", "affiliation": { "@type": "Organization", "name": "Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA." } }, { "@type": "Person", "name": "Joshua M Diamond", "url": "https://questionsmedicales.fr/author/Joshua%20M%20Diamond", "affiliation": { "@type": "Organization", "name": "Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania." } }, { "@type": "Person", "name": "Hisashi Oishi", "url": "https://questionsmedicales.fr/author/Hisashi%20Oishi", "affiliation": { "@type": "Organization", "name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan. hisashi.oishi.c7@tohoku.ac.jp." } }, { "@type": "Person", "name": "Takashi Hirama", "url": "https://questionsmedicales.fr/author/Takashi%20Hirama", "affiliation": { "@type": "Organization", "name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Independent replication of advanced brain age in mild cognitive impairment and dementia: detection of future cognitive dysfunction.", "datePublished": "2022-08-16", "url": "https://questionsmedicales.fr/article/35974140", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41380-022-01728-y" } }, { "@type": "ScholarlyArticle", "name": "[Immunological mechanisms of cognitive dysfunction under systemic therapy in metastatic melanoma].", "datePublished": "2022-11-09", "url": "https://questionsmedicales.fr/article/36350371", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00105-022-05070-w" } }, { "@type": "ScholarlyArticle", "name": "Polysomnographic Predictors of Sleep, Motor, and Cognitive Dysfunction Progression in Parkinson's Disease.", "datePublished": "2022-08-22", "url": "https://questionsmedicales.fr/article/35994190", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11910-022-01226-2" } }, { "@type": "ScholarlyArticle", "name": "Acute disease induced cognitive dysfunction in older patients - an unrecognized syndrome.", "datePublished": "2022-08-15", "url": "https://questionsmedicales.fr/article/35971082", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12877-022-03323-w" } }, { "@type": "ScholarlyArticle", "name": "Effects of Dexmedetomidine Anesthesia on Early Postoperative Cognitive Dysfunction in Elderly Patients.", "datePublished": "2022-07-21", "url": "https://questionsmedicales.fr/article/35864562", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acschemneuro.2c00173" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Maladies pulmonaires", "item": "https://questionsmedicales.fr/mesh/D008171" }, { "@type": "ListItem", "position": 4, "name": "Poumon hyperclair", "item": "https://questionsmedicales.fr/mesh/D019568" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Poumon hyperclair - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Poumon hyperclair", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Poumon hyperclair", "description": "Comment diagnostiquer un poumon hyperclair ?\nQuels examens complémentaires sont utiles ?\nQuels signes radiologiques indiquent un poumon hyperclair ?\nLe poumon hyperclair est-il toujours pathologique ?\nQuel rôle joue l'anamnèse dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Cognitive+Dysfunction&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Poumon hyperclair", "description": "Quels symptômes sont associés au poumon hyperclair ?\nLe poumon hyperclair provoque-t-il des douleurs ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nComment la toux se manifeste-t-elle ?\nLe poumon hyperclair est-il asymptomatique ?", "url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Cognitive+Dysfunction&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Poumon hyperclair", "description": "Comment prévenir le poumon hyperclair ?\nY a-t-il des vaccinations recommandées ?\nComment surveiller la santé pulmonaire ?\nLes exercices respiratoires aident-ils ?\nQuelles habitudes de vie adopter ?", "url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Cognitive+Dysfunction&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Poumon hyperclair", "description": "Quel traitement pour un poumon hyperclair ?\nLes antibiotiques sont-ils nécessaires ?\nQuand envisager une intervention chirurgicale ?\nLes corticostéroïdes sont-ils efficaces ?\nComment gérer les symptômes respiratoires ?", "url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Cognitive+Dysfunction&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Poumon hyperclair", "description": "Quelles complications peuvent survenir ?\nLe poumon hyperclair peut-il entraîner des infections ?\nComment gérer les complications ?\nLe poumon hyperclair est-il réversible ?\nQuels sont les risques à long terme ?", "url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Cognitive+Dysfunction&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Poumon hyperclair", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes maladies pulmonaires prédisposent-elles ?\nLe mode de vie joue-t-il un rôle ?\nLes allergies sont-elles un facteur ?", "url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Cognitive+Dysfunction&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un poumon hyperclair ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par radiographie thoracique et éventuellement par scanner." } }, { "@type": "Question", "name": "Quels examens complémentaires sont utiles ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests fonctionnels respiratoires et une tomodensitométrie peuvent être réalisés." } }, { "@type": "Question", "name": "Quels signes radiologiques indiquent un poumon hyperclair ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une diminution de la densité pulmonaire et une augmentation de la transparence sont observées." } }, { "@type": "Question", "name": "Le poumon hyperclair est-il toujours pathologique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, il peut être physiologique chez les jeunes enfants ou en cas d'hyperinflation." } }, { "@type": "Question", "name": "Quel rôle joue l'anamnèse dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'anamnèse aide à identifier des antécédents de maladies respiratoires ou d'exposition." } }, { "@type": "Question", "name": "Quels symptômes sont associés au poumon hyperclair ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure une dyspnée, une toux ou des douleurs thoraciques." } }, { "@type": "Question", "name": "Le poumon hyperclair provoque-t-il des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Pas directement, mais des douleurs peuvent survenir en raison de maladies sous-jacentes." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les enfants ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent présenter des symptômes respiratoires aigus ou chroniques." } }, { "@type": "Question", "name": "Comment la toux se manifeste-t-elle ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "La toux peut être sèche ou productive, selon la cause sous-jacente du poumon hyperclair." } }, { "@type": "Question", "name": "Le poumon hyperclair est-il asymptomatique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être asymptomatique, surtout dans les cas d'hyperinflation bénigne." } }, { "@type": "Question", "name": "Comment prévenir le poumon hyperclair ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et les polluants environnementaux peut réduire les risques." } }, { "@type": "Question", "name": "Y a-t-il des vaccinations recommandées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la vaccination contre la grippe et le pneumocoque est conseillée." } }, { "@type": "Question", "name": "Comment surveiller la santé pulmonaire ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers et des tests de fonction pulmonaire sont recommandés." } }, { "@type": "Question", "name": "Les exercices respiratoires aident-ils ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent améliorer la capacité pulmonaire et la santé respiratoire." } }, { "@type": "Question", "name": "Quelles habitudes de vie adopter ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Adopter une alimentation équilibrée et faire de l'exercice régulièrement est bénéfique." } }, { "@type": "Question", "name": "Quel traitement pour un poumon hyperclair ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la cause sous-jacente, comme des bronchodilatateurs pour l'asthme." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils ne sont nécessaires que si une infection bactérienne est suspectée." } }, { "@type": "Question", "name": "Quand envisager une intervention chirurgicale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une chirurgie peut être envisagée en cas de complications graves comme un pneumothorax." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être utilisés pour réduire l'inflammation dans certaines conditions." } }, { "@type": "Question", "name": "Comment gérer les symptômes respiratoires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des bronchodilatateurs et des thérapies respiratoires peuvent aider à soulager les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme le pneumothorax ou l'insuffisance respiratoire peuvent se produire." } }, { "@type": "Question", "name": "Le poumon hyperclair peut-il entraîner des infections ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une hyperinflation peut prédisposer à des infections pulmonaires." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion dépend de la complication, nécessitant parfois une hospitalisation." } }, { "@type": "Question", "name": "Le poumon hyperclair est-il réversible ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la cause; certaines conditions peuvent être réversibles avec un traitement." } }, { "@type": "Question", "name": "Quels sont les risques à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent une détérioration de la fonction pulmonaire et des complications chroniques." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'exposition à des polluants et des antécédents familiaux de maladies respiratoires." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout chez les fumeurs et les personnes exposées." } }, { "@type": "Question", "name": "Les maladies pulmonaires prédisposent-elles ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de poumon hyperclair." } }, { "@type": "Question", "name": "Le mode de vie joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les allergies sont-elles un facteur ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines allergies respiratoires peuvent contribuer à des problèmes pulmonaires, y compris l'hyperclarté." } } ] } ] }

Sources (10000 au total)

Polysomnographic Predictors of Sleep, Motor, and Cognitive Dysfunction Progression in Parkinson's Disease.

Sleep disturbances are an important nonmotor feature of Parkinson's disease (PD) that can cause polysomnographic (PSG) alterations. These alterations are already present in early PD and may be associa... Nineteen longitudinal cohort studies were included. Their main findings were that (1) REM sleep behavioral events, REM sleep without atonia (RSWA), and electroencephalography (EEG) changes (mainly mic...

Acute disease induced cognitive dysfunction in older patients - an unrecognized syndrome.

It is unknown, how many older hospitalized patients experience cognitive changes independently from delirium.... In this retrospective study, cognitive function was assessed with the Montreal Cognitive Assessment on admission and discharge in 103 acute care geriatric hospital patients.... Mean age was 80.8 ± 7.3 years. The total MoCA score on admission was 17.8 (±4.5) and at discharge 17.7 (±4.4). The mean difference of the total MoCA score was - 0.1 (±3.5). 12 (11.7%) patients suffere... Cognitive changes frequently occur during acute disease of geriatric patients independently from delirium. We propose the term "acute disease induced cognitive dysfunction" (ADICD) for this entity.... German Clinical trial register (DRKS-ID: DRKS00025157 on 28.04.2021)....

Brain-immune interaction mechanisms: Implications for cognitive dysfunction in psychiatric disorders.

Cognitive dysfunction has been identified as a major symptom of a series of psychiatric disorders. Multidisciplinary studies have shown that cognitive dysfunction is monitored by a two-way interaction... In this review, we summarized the relevant research to uncover our comprehension of the brain-immune interaction mechanisms underlying cognitive decline.... The pathophysiological mechanisms of brain-immune interactions in psychiatric-based cognitive dysfunction involve several specific immune molecules and their associated signaling pathways, impairments... Therefore, this review may provide a better theoretical basis for integrative therapeutic considerations for psychiatric disorders associated with cognitive dysfunction....

Cognitive dysfunction in drug-naïve late-onset temporal lobe epilepsy.

To evaluate cognitive functions including memory in middle-aged and elderly patients with antiseizure drug-naïve late-onset temporal lobe epilepsy (TLE).... We performed assessments with the Wechsler Adult Intelligence Scale-III (WAIS-III) and Wechsler Memory Scale-Revised (WMS-R) in 26 antiseizure drug-naïve patients with late-onset TLE, in comparison to... Patients with epilepsy had a significantly lower score than healthy controls in the verbal intelligence quotient (IQ), the performance IQ, and full-scale IQ in intelligence testing. Patients showed si... Patients with antiseizure drug-naïve late-onset TLE displayed cognitive deficits including the domains of memory by using standard clinical neuropsychological test. Patients with late-onset epilepsy n...

Risk factors for post-COVID cognitive dysfunctions: the impact of psychosocial vulnerability.

Cognitive dysfunction is a well-established manifestation of the post-COVID syndrome. Psychological vulnerability to stressors can modify disease trajectories, causing long-term risk for negative outc... All subjects were submitted to a comprehensive neuropsychological battery and an assessment of perceived loneliness, post-traumatic stress, and changes in anxiety and depression levels. A social vulne... Forty-five percent of individuals showed cognitive impairments, with predominant memory and executive deficits. Post-traumatic stress disorder was clinically relevant in 44% of the sample. Social vuln... These findings suggest that psychosocial assessment of post-COVID patients can detect fragile individuals at risk of cognitive impairments. Dedicated psychological support services may play a useful r...

Evoked mid-frontal activity predicts cognitive dysfunction in Parkinson's disease.

Cognitive dysfunction is a major feature of Parkinson's disease (PD), but the pathophysiology remains unknown. One potential mechanism is abnormal low-frequency cortical rhythms which engage cognitive... We recruited 100 patients with PD and 49 demographically similar control participants who completed a series of cognitive control tasks, including the Simon, oddball and interval-timing tasks. We focu... We found that PD-related cognitive dysfunction was associated with increased response latencies and decreased mid-frontal delta power across all tasks. Within patients with PD, the first principal com... These data demonstrate that cue-evoked mid-frontal delta/theta rhythms directly relate to cognition in PD. Our results provide insight into the nature of low-frequency frontal rhythms and suggest that...

Cognitive dysfunction and neurometabolic alternations in major depressive disorder with gastrointestinal symptoms.

Brain biochemical abnormalities have been associated with major depressive disorder (MDD) and cognitive impairments. However, the cognitive performance and neurometabolic alterations of MDD patients a... Fifty MDD patients with GI symptoms (GI group), 46 patients without GI symptoms (NGI group) and 50 demographically matched healthy controls (HCs) underwent Measurement and Treatment Research to Improv... Compared to HCs, participants in both the GI and NGI groups had significantly reduced performance in the six MCCB cognitive domains (all p < 0.05), except for reasoning and problem solving. Higher Cho... Our findings suggest that MDD patients with GI symptoms may exhibit greater neurometabolic alternations than those without GI symptoms, while both show similar cognitive dysfunction. In addition, neur...